Global Legionnaire Disease Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 200264
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Legionnaire Disease Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Legionnaire Disease Testing size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Legionnaire Disease Testing market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Legionnaire Disease Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Urinary Antigen Testing

Direct Fluorescent Antibody (DFA) Stain

Combination Testing (Culture and Urinary Antigen Testing)

Others

Market segment by Application, can be divided into

Hospitals

Diagnostic Laboratories

Research Centers

Others

Market segment by players, this report covers

Danaher

Bio-Rad

Abbott

Roche

Thermo Fischer Scientific

BD

Aquacert

BioMérieux

Idexx

Albagaia

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Legionnaire Disease Testing

1.2 Classification of Legionnaire Disease Testing by Type

1.2.1 Overview: Global Legionnaire Disease Testing Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Legionnaire Disease Testing Revenue Market Share by Type in 2020

1.2.3 Urinary Antigen Testing

1.2.4 Direct Fluorescent Antibody (DFA) Stain

1.2.5 Combination Testing (Culture and Urinary Antigen Testing)

1.2.6 Others

1.3 Global Legionnaire Disease Testing Market by Application

1.3.1 Overview: Global Legionnaire Disease Testing Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospitals

1.3.3 Diagnostic Laboratories

1.3.4 Research Centers

1.3.5 Others

1.4 Global Legionnaire Disease Testing Market Size & Forecast

1.5 Global Legionnaire Disease Testing Market Size and Forecast by Region

1.5.1 Global Legionnaire Disease Testing Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Legionnaire Disease Testing Market Size by Region, (2016-2021)

1.5.3 North America Legionnaire Disease Testing Market Size and Prospect (2016-2026)

1.5.4 Europe Legionnaire Disease Testing Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Legionnaire Disease Testing Market Size and Prospect (2016-2026)

1.5.6 South America Legionnaire Disease Testing Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Legionnaire Disease Testing Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Legionnaire Disease Testing Market Drivers

1.6.2 Legionnaire Disease Testing Market Restraints

1.6.3 Legionnaire Disease Testing Trends Analysis

2 Company Profiles

2.1 Danaher

2.1.1 Danaher Details

2.1.2 Danaher Major Business

2.1.3 Danaher Legionnaire Disease Testing Product and Solutions

2.1.4 Danaher Legionnaire Disease Testing Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Danaher Recent Developments and Future Plans

2.2 Bio-Rad

2.2.1 Bio-Rad Details

2.2.2 Bio-Rad Major Business

2.2.3 Bio-Rad Legionnaire Disease Testing Product and Solutions

2.2.4 Bio-Rad Legionnaire Disease Testing Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Bio-Rad Recent Developments and Future Plans

2.3 Abbott

2.3.1 Abbott Details

2.3.2 Abbott Major Business

2.3.3 Abbott Legionnaire Disease Testing Product and Solutions

2.3.4 Abbott Legionnaire Disease Testing Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Abbott Recent Developments and Future Plans

2.4 Roche

2.4.1 Roche Details

2.4.2 Roche Major Business

2.4.3 Roche Legionnaire Disease Testing Product and Solutions

2.4.4 Roche Legionnaire Disease Testing Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Roche Recent Developments and Future Plans

2.5 Thermo Fischer Scientific

2.5.1 Thermo Fischer Scientific Details

2.5.2 Thermo Fischer Scientific Major Business

2.5.3 Thermo Fischer Scientific Legionnaire Disease Testing Product and Solutions

2.5.4 Thermo Fischer Scientific Legionnaire Disease Testing Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Thermo Fischer Scientific Recent Developments and Future Plans

2.6 BD

2.6.1 BD Details

2.6.2 BD Major Business

2.6.3 BD Legionnaire Disease Testing Product and Solutions

2.6.4 BD Legionnaire Disease Testing Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 BD Recent Developments and Future Plans

2.7 Aquacert

2.7.1 Aquacert Details

2.7.2 Aquacert Major Business

2.7.3 Aquacert Legionnaire Disease Testing Product and Solutions

2.7.4 Aquacert Legionnaire Disease Testing Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Aquacert Recent Developments and Future Plans

2.8 BioMérieux

2.8.1 BioMérieux Details

2.8.2 BioMérieux Major Business

2.8.3 BioMérieux Legionnaire Disease Testing Product and Solutions

2.8.4 BioMérieux Legionnaire Disease Testing Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 BioMérieux Recent Developments and Future Plans

2.9 Idexx

2.9.1 Idexx Details

2.9.2 Idexx Major Business

2.9.3 Idexx Legionnaire Disease Testing Product and Solutions

2.9.4 Idexx Legionnaire Disease Testing Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Idexx Recent Developments and Future Plans

2.10 Albagaia

2.10.1 Albagaia Details

2.10.2 Albagaia Major Business

2.10.3 Albagaia Legionnaire Disease Testing Product and Solutions

2.10.4 Albagaia Legionnaire Disease Testing Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Albagaia Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Legionnaire Disease Testing Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Legionnaire Disease Testing Players Market Share

3.2.2 Top 10 Legionnaire Disease Testing Players Market Share

3.2.3 Market Competition Trend

3.3 Legionnaire Disease Testing Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Legionnaire Disease Testing Revenue and Market Share by Type (2016-2021)

4.2 Global Legionnaire Disease Testing Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Legionnaire Disease Testing Revenue Market Share by Application (2016-2021)

5.2 Legionnaire Disease Testing Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Legionnaire Disease Testing Revenue by Type (2016-2026)

6.2 North America Legionnaire Disease Testing Revenue by Application (2016-2026)

6.3 North America Legionnaire Disease Testing Market Size by Country

6.3.1 North America Legionnaire Disease Testing Revenue by Country (2016-2026)

6.3.2 United States Legionnaire Disease Testing Market Size and Forecast (2016-2026)

6.3.3 Canada Legionnaire Disease Testing Market Size and Forecast (2016-2026)

6.3.4 Mexico Legionnaire Disease Testing Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Legionnaire Disease Testing Revenue by Type (2016-2026)

7.2 Europe Legionnaire Disease Testing Revenue by Application (2016-2026)

7.3 Europe Legionnaire Disease Testing Market Size by Country

7.3.1 Europe Legionnaire Disease Testing Revenue by Country (2016-2026)

7.3.2 Germany Legionnaire Disease Testing Market Size and Forecast (2016-2026)

7.3.3 France Legionnaire Disease Testing Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Legionnaire Disease Testing Market Size and Forecast (2016-2026)

7.3.5 Russia Legionnaire Disease Testing Market Size and Forecast (2016-2026)

7.3.6 Italy Legionnaire Disease Testing Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Legionnaire Disease Testing Revenue by Type (2016-2026)

8.2 Asia-Pacific Legionnaire Disease Testing Revenue by Application (2016-2026)

8.3 Asia-Pacific Legionnaire Disease Testing Market Size by Region

8.3.1 Asia-Pacific Legionnaire Disease Testing Revenue by Region (2016-2026)

8.3.2 China Legionnaire Disease Testing Market Size and Forecast (2016-2026)

8.3.3 Japan Legionnaire Disease Testing Market Size and Forecast (2016-2026)

8.3.4 South Korea Legionnaire Disease Testing Market Size and Forecast (2016-2026)

8.3.5 India Legionnaire Disease Testing Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Legionnaire Disease Testing Market Size and Forecast (2016-2026)

8.3.7 Australia Legionnaire Disease Testing Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Legionnaire Disease Testing Revenue by Type (2016-2026)

9.2 South America Legionnaire Disease Testing Revenue by Application (2016-2026)

9.3 South America Legionnaire Disease Testing Market Size by Country

9.3.1 South America Legionnaire Disease Testing Revenue by Country (2016-2026)

9.3.2 Brazil Legionnaire Disease Testing Market Size and Forecast (2016-2026)

9.3.3 Argentina Legionnaire Disease Testing Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Legionnaire Disease Testing Revenue by Type (2016-2026)

10.2 Middle East & Africa Legionnaire Disease Testing Revenue by Application (2016-2026)

10.3 Middle East & Africa Legionnaire Disease Testing Market Size by Country

10.3.1 Middle East & Africa Legionnaire Disease Testing Revenue by Country (2016-2026)

10.3.2 Turkey Legionnaire Disease Testing Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Legionnaire Disease Testing Market Size and Forecast (2016-2026)

10.3.4 UAE Legionnaire Disease Testing Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Legionnaire Disease Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Legionnaire Disease Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Legionnaire Disease Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Legionnaire Disease Testing Revenue (USD Million) by Region (2016-2021)

Table 5. Global Legionnaire Disease Testing Revenue Market Share by Region (2021-2026)

Table 6. Danaher Corporate Information, Head Office, and Major Competitors

Table 7. Danaher Major Business

Table 8. Danaher Legionnaire Disease Testing Product and Solutions

Table 9. Danaher Legionnaire Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Bio-Rad Corporate Information, Head Office, and Major Competitors

Table 11. Bio-Rad Major Business

Table 12. Bio-Rad Legionnaire Disease Testing Product and Solutions

Table 13. Bio-Rad Legionnaire Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Abbott Corporate Information, Head Office, and Major Competitors

Table 15. Abbott Major Business

Table 16. Abbott Legionnaire Disease Testing Product and Solutions

Table 17. Abbott Legionnaire Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Roche Corporate Information, Head Office, and Major Competitors

Table 19. Roche Major Business

Table 20. Roche Legionnaire Disease Testing Product and Solutions

Table 21. Roche Legionnaire Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Thermo Fischer Scientific Corporate Information, Head Office, and Major Competitors

Table 23. Thermo Fischer Scientific Major Business

Table 24. Thermo Fischer Scientific Legionnaire Disease Testing Product and Solutions

Table 25. Thermo Fischer Scientific Legionnaire Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. BD Corporate Information, Head Office, and Major Competitors

Table 27. BD Major Business

Table 28. BD Legionnaire Disease Testing Product and Solutions

Table 29. BD Legionnaire Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Aquacert Corporate Information, Head Office, and Major Competitors

Table 31. Aquacert Major Business

Table 32. Aquacert Legionnaire Disease Testing Product and Solutions

Table 33. Aquacert Legionnaire Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. BioMérieux Corporate Information, Head Office, and Major Competitors

Table 35. BioMérieux Major Business

Table 36. BioMérieux Legionnaire Disease Testing Product and Solutions

Table 37. BioMérieux Legionnaire Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Idexx Corporate Information, Head Office, and Major Competitors

Table 39. Idexx Major Business

Table 40. Idexx Legionnaire Disease Testing Product and Solutions

Table 41. Idexx Legionnaire Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Albagaia Corporate Information, Head Office, and Major Competitors

Table 43. Albagaia Major Business

Table 44. Albagaia Legionnaire Disease Testing Product and Solutions

Table 45. Albagaia Legionnaire Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Global Legionnaire Disease Testing Revenue (USD Million) by Players (2019-2021)

Table 47. Global Legionnaire Disease Testing Revenue Share by Players (2019-2021)

Table 48. Breakdown of Legionnaire Disease Testing by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Legionnaire Disease Testing Players Head Office, Products and Services Provided

Table 50. Legionnaire Disease Testing Mergers & Acquisitions in the Past Five Years

Table 51. Legionnaire Disease Testing New Entrants and Expansion Plans

Table 52. Global Legionnaire Disease Testing Revenue (USD Million) by Type (2016-2021)

Table 53. Global Legionnaire Disease Testing Revenue Share by Type (2016-2021)

Table 54. Global Legionnaire Disease Testing Revenue Forecast by Type (2021-2026)

Table 55. Global Legionnaire Disease Testing Revenue by Application (2016-2021)

Table 56. Global Legionnaire Disease Testing Revenue Forecast by Application (2021-2026)

Table 57. North America Legionnaire Disease Testing Revenue by Type (2016-2021) & (USD Million)

Table 58. North America Legionnaire Disease Testing Revenue by Type (2021-2026) & (USD Million)

Table 59. North America Legionnaire Disease Testing Revenue by Application (2016-2021) & (USD Million)

Table 60. North America Legionnaire Disease Testing Revenue by Application (2021-2026) & (USD Million)

Table 61. North America Legionnaire Disease Testing Revenue by Country (2016-2021) & (USD Million)

Table 62. North America Legionnaire Disease Testing Revenue by Country (2021-2026) & (USD Million)

Table 63. Europe Legionnaire Disease Testing Revenue by Type (2016-2021) & (USD Million)

Table 64. Europe Legionnaire Disease Testing Revenue by Type (2021-2026) & (USD Million)

Table 65. Europe Legionnaire Disease Testing Revenue by Application (2016-2021) & (USD Million)

Table 66. Europe Legionnaire Disease Testing Revenue by Application (2021-2026) & (USD Million)

Table 67. Europe Legionnaire Disease Testing Revenue by Country (2016-2021) & (USD Million)

Table 68. Europe Legionnaire Disease Testing Revenue by Country (2021-2026) & (USD Million)

Table 69. Asia-Pacific Legionnaire Disease Testing Revenue by Type (2016-2021) & (USD Million)

Table 70. Asia-Pacific Legionnaire Disease Testing Revenue by Type (2021-2026) & (USD Million)

Table 71. Asia-Pacific Legionnaire Disease Testing Revenue by Application (2016-2021) & (USD Million)

Table 72. Asia-Pacific Legionnaire Disease Testing Revenue by Application (2021-2026) & (USD Million)

Table 73. Asia-Pacific Legionnaire Disease Testing Revenue by Region (2016-2021) & (USD Million)

Table 74. Asia-Pacific Legionnaire Disease Testing Revenue by Region (2021-2026) & (USD Million)

Table 75. South America Legionnaire Disease Testing Revenue by Type (2016-2021) & (USD Million)

Table 76. South America Legionnaire Disease Testing Revenue by Type (2021-2026) & (USD Million)

Table 77. South America Legionnaire Disease Testing Revenue by Application (2016-2021) & (USD Million)

Table 78. South America Legionnaire Disease Testing Revenue by Application (2021-2026) & (USD Million)

Table 79. South America Legionnaire Disease Testing Revenue by Country (2016-2021) & (USD Million)

Table 80. South America Legionnaire Disease Testing Revenue by Country (2021-2026) & (USD Million)

Table 81. Middle East & Africa Legionnaire Disease Testing Revenue by Type (2016-2021) & (USD Million)

Table 82. Middle East & Africa Legionnaire Disease Testing Revenue by Type (2021-2026) & (USD Million)

Table 83. Middle East & Africa Legionnaire Disease Testing Revenue by Application (2016-2021) & (USD Million)

Table 84. Middle East & Africa Legionnaire Disease Testing Revenue by Application (2021-2026) & (USD Million)

Table 85. Middle East & Africa Legionnaire Disease Testing Revenue by Country (2016-2021) & (USD Million)

Table 86. Middle East & Africa Legionnaire Disease Testing Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Legionnaire Disease Testing Picture

Figure 2. Global Legionnaire Disease Testing Revenue Market Share by Type in 2020

Figure 3. Urinary Antigen Testing

Figure 4. Direct Fluorescent Antibody (DFA) Stain

Figure 5. Combination Testing (Culture and Urinary Antigen Testing)

Figure 6. Others

Figure 7. Legionnaire Disease Testing Revenue Market Share by Application in 2020

Figure 8. Hospitals Picture

Figure 9. Diagnostic Laboratories Picture

Figure 10. Research Centers Picture

Figure 11. Others Picture

Figure 12. Global Legionnaire Disease Testing Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 13. Global Legionnaire Disease Testing Revenue and Forecast (2016-2026) & (USD Million)

Figure 14. Global Legionnaire Disease Testing Revenue Market Share by Region (2016-2026)

Figure 15. Global Legionnaire Disease Testing Revenue Market Share by Region in 2020

Figure 16. North America Legionnaire Disease Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 17. Europe Legionnaire Disease Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Asia-Pacific Legionnaire Disease Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. South America Legionnaire Disease Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Middle East and Africa Legionnaire Disease Testing Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Legionnaire Disease Testing Market Drivers

Figure 22. Legionnaire Disease Testing Market Restraints

Figure 23. Legionnaire Disease Testing Market Trends

Figure 24. Danaher Recent Developments and Future Plans

Figure 25. Bio-Rad Recent Developments and Future Plans

Figure 26. Abbott Recent Developments and Future Plans

Figure 27. Roche Recent Developments and Future Plans

Figure 28. Thermo Fischer Scientific Recent Developments and Future Plans

Figure 29. BD Recent Developments and Future Plans

Figure 30. Aquacert Recent Developments and Future Plans

Figure 31. BioMérieux Recent Developments and Future Plans

Figure 32. Idexx Recent Developments and Future Plans

Figure 33. Albagaia Recent Developments and Future Plans

Figure 34. Global Legionnaire Disease Testing Revenue Share by Players in 2020

Figure 35. Legionnaire Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 36. Global Top 3 Players Legionnaire Disease Testing Revenue Market Share in 2020

Figure 37. Global Top 10 Players Legionnaire Disease Testing Revenue Market Share in 2020

Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 39. Global Legionnaire Disease Testing Revenue Share by Type in 2020

Figure 40. Global Legionnaire Disease Testing Market Share Forecast by Type (2021-2026)

Figure 41. Global Legionnaire Disease Testing Revenue Share by Application in 2020

Figure 42. Global Legionnaire Disease Testing Market Share Forecast by Application (2021-2026)

Figure 43. North America Legionnaire Disease Testing Sales Market Share by Type (2016-2026)

Figure 44. North America Legionnaire Disease Testing Sales Market Share by Application (2016-2026)

Figure 45. North America Legionnaire Disease Testing Revenue Market Share by Country (2016-2026)

Figure 46. United States Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 47. Canada Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 48. Mexico Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Europe Legionnaire Disease Testing Sales Market Share by Type (2016-2026)

Figure 50. Europe Legionnaire Disease Testing Sales Market Share by Application (2016-2026)

Figure 51. Europe Legionnaire Disease Testing Revenue Market Share by Country (2016-2026)

Figure 52. Germany Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. France Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. United Kingdom Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. Russia Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Italy Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Asia-Pacific Legionnaire Disease Testing Sales Market Share by Type (2016-2026)

Figure 58. Asia-Pacific Legionnaire Disease Testing Sales Market Share by Application (2016-2026)

Figure 59. Asia-Pacific Legionnaire Disease Testing Revenue Market Share by Region (2016-2026)

Figure 60. China Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. Japan Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. South Korea Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. India Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Southeast Asia Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Australia Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. South America Legionnaire Disease Testing Sales Market Share by Type (2016-2026)

Figure 67. South America Legionnaire Disease Testing Sales Market Share by Application (2016-2026)

Figure 68. South America Legionnaire Disease Testing Revenue Market Share by Country (2016-2026)

Figure 69. Brazil Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Argentina Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. Middle East and Africa Legionnaire Disease Testing Sales Market Share by Type (2016-2026)

Figure 72. Middle East and Africa Legionnaire Disease Testing Sales Market Share by Application (2016-2026)

Figure 73. Middle East and Africa Legionnaire Disease Testing Revenue Market Share by Country (2016-2026)

Figure 74. Turkey Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Saudi Arabia Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. UAE Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Methodology

Figure 78. Research Process and Data Source